Saxon Interests Inc. Purchases 1,136 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Saxon Interests Inc. boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 49.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,437 shares of the healthcare conglomerate’s stock after acquiring an additional 1,136 shares during the period. Saxon Interests Inc.’s holdings in UnitedHealth Group were worth $1,738,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Bristol Gate Capital Partners Inc. grew its stake in shares of UnitedHealth Group by 7.2% during the second quarter. Bristol Gate Capital Partners Inc. now owns 184,925 shares of the healthcare conglomerate’s stock worth $94,175,000 after purchasing an additional 12,372 shares during the period. Intech Investment Management LLC boosted its stake in UnitedHealth Group by 1.0% during the 2nd quarter. Intech Investment Management LLC now owns 337,254 shares of the healthcare conglomerate’s stock worth $171,750,000 after acquiring an additional 3,348 shares during the last quarter. Brighton Jones LLC increased its stake in UnitedHealth Group by 47.4% in the second quarter. Brighton Jones LLC now owns 26,302 shares of the healthcare conglomerate’s stock valued at $13,394,000 after purchasing an additional 8,458 shares in the last quarter. Ieq Capital LLC grew its holdings in shares of UnitedHealth Group by 4.6% in the 2nd quarter. Ieq Capital LLC now owns 62,584 shares of the healthcare conglomerate’s stock valued at $31,872,000 after buying an additional 2,775 shares during the period. Finally, Benjamin F. Edwards & Company Inc. raised its stake in UnitedHealth Group by 4.8% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 39,031 shares of the healthcare conglomerate’s stock worth $19,877,000 after buying an additional 1,770 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

UNH opened at $510.03 on Friday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The business has a 50 day moving average of $551.50 and a 200-day moving average of $562.62. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $469.37 billion, a price-to-earnings ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the firm earned $5.83 earnings per share. The company’s revenue was up 6.8% on a year-over-year basis. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.65%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the company. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Barclays cut their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday. Stephens raised their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Two research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.